Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.06 | 0.7 |
mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |